Relationship between respiratory muscle function and quality of life in sarcoidosis

In sarcoidosis, pulmonary and general symptoms often do not correlate with radiographic stage and routinely performed lung function tests. Asymptomatic muscle involvement in sarcoidosis is common, but little is known about respiratory muscle involvement. The aim of this study was to investigate any relationships between persistent complaints and/or quality of life and respiratory muscle strength and endurance, respectively. Measurements of maximal inspiratory and expiratory mouth pressures (PI,max and PE,max), respiratory muscle endurance and routine lung function were made in 18 patients with sarcoidosis. To assess health status and quality of life, patients completed the Sickness Impact Profile (SIP). Respiratory muscle strength and endurance time were lower in the patient group than in a group of healthy controls (p=0.05). Compared to a general population, the patients with sarcoidosis were found to be limited in physical and psychosocial functioning. The respiratory muscle endurance time correlated with the SIP subscales "mobility" (r=-0.56; p<0.01), and "body care and movement" (r=-0.79; p<0.001). The total lung capacity (TLC), inspiratory vital capacity (IVC) and forced expiratory volume in one second (FEV1) were normal in all subjects. In conclusion, patients with sarcoidosis and normal lung function showed reduced respiratory muscle strength and endurance time. Correlations were found between these indices and both symptoms and certain Sickness Impact Profile domains. Therefore, we suggest inclusion of measurements of respiratory muscle strength in the assessment and follow-up of patients with sarcoidosis.

This article has been cited by other articles:

				J. COLANGELO and D. L WRIGHT Sarcoidosis: A Primer Radiol. Technol., September 1, 2008; 80(1): 49 - 63. [Abstract] [Full Text] [PDF]

				H.-J. Kabitz, F. Lang, S. Walterspacher, S. Sorichter, J. Muller-Quernheim, and W. Windisch Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest, November 1, 2006; 130(5): 1496 - 1502. [Abstract] [Full Text] [PDF]

				U Costabel Skeletal muscle weakness, fatigue and sarcoidosis Thorax, January 1, 2005; 60(1): 1 - 2. [Full Text] [PDF]

				M A Spruit, M J Thomeer, R Gosselink, T Troosters, A Kasran, A J T Debrock, M G Demedts, and M Decramer Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status Thorax, January 1, 2005; 60(1): 32 - 38. [Abstract] [Full Text] [PDF]

				A. Baydur, M. Alsalek, S. G. Louie, and O. P. Sharma Respiratory Muscle Strength, Lung Function, and Dyspnea in Patients With Sarcoidosis Chest, July 1, 2001; 120(1): 102 - 108. [Abstract] [Full Text] [PDF]

				T. Y. Martinez, C. A. C. Pereira, M. L. dos Santos, R. M. Ciconelli, S. M. Guimaraes, and J. A. B. Martinez Evaluation of the Short-Form 36-Item Questionnaire to Measure Health-Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis Chest, June 1, 2000; 117(6): 1627 - 1632. [Abstract] [Full Text] [PDF]